blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1487425

EP1487425 - USE OF A VANILLOID AS AN ANTI-SNORING ELEMENT [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.02.2006
Database last updated on 24.08.2024
Most recent event   Tooltip10.02.2006Application deemed to be withdrawnpublished on 29.03.2006  [2006/13]
Applicant(s)For all designated states
LMD
Rue du Pra de Serre
63960 Veyre Monton / FR
[N/P]
Former [2004/52]For all designated states
Lmd
Rue du Pra de Serre
63960 Veyre Monton / FR
Inventor(s)01 / JEAN, Daniel
283, rue de la Chaussade
F-63270 Vic-Le-Comte / FR
02 / CARIEL, Léon
6, rue de Seine
F-75006 Paris / FR
 [2004/52]
Representative(s)Ahner, Francis, et al
Cabinet Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[N/P]
Former [2004/52]Ahner, Francis, et al
Cabinet Régimbeau 20, rue de Chazelles
75847 Paris cedex 17 / FR
Application number, filing date03738193.625.03.2003
[2004/52]
WO2003FR00936
Priority number, dateFR2002000368125.03.2002         Original published format: FR 0203681
[2004/52]
Filing languageFR
Procedural languageFR
PublicationType: A2 Application without search report
No.:WO03080036
Date:02.10.2003
Language:FR
[2003/40]
Type: A2 Application without search report 
No.:EP1487425
Date:22.12.2004
Language:FR
The application published by WIPO in one of the EPO official languages on 02.10.2003 takes the place of the publication of the European patent application.
[2004/52]
Search report(s)International search report - published on:EP19.02.2004
ClassificationIPC:A61K31/121, A61K31/165, A61K35/78, A61P11/00
[2004/52]
CPC:
A61K31/121 (EP,US); A61K31/16 (EP,US); A61K31/36 (EP,US);
A61P11/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2004/52]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:VERWENDUNG EINES VANILLOIDS ZUR BEHANDLUNG DES SCHNARCHENS[2004/52]
English:USE OF A VANILLOID AS AN ANTI-SNORING ELEMENT[2004/52]
French:UTILISATION D UN VANILLOIDE COMME ANTI-RONFLEMENT[2004/52]
Entry into regional phase18.10.2004National basic fee paid 
18.10.2004Designation fee(s) paid 
18.10.2004Examination fee paid 
Examination procedure18.10.2004Examination requested  [2004/52]
14.12.2004Despatch of a communication from the examining division (Time limit: M04)
22.12.2004Reply to a communication from the examining division
09.02.2005Despatch of a communication from the examining division (Time limit: M06)
20.08.2005Application deemed to be withdrawn, date of legal effect  [2006/13]
27.09.2005Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2006/13]
Fees paidRenewal fee
18.10.2004Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]EP0646372  (MEDICHEMIE AG [CH]) [X] 1,2,7,8 * abstract * * claim 1 * * column 2, line 48 - column 3, line 28 * [Y] 3-6;
 [DX]US5804211  (ROBERTSON LYDIA [US], et al) [DX] 1-8 * abstract * * column 1, line 4 - line 45 * * column 3, line 66 - column 4, line 26 * * column 5, line 10 - line 20 * * column 9, line 1 - line 39 *;
 [DX]US5603935  (JIAN WENG W [CN], et al) [DX] 1-8 * abstract * * column 2, line 17 - line 44 *;
 [DX]US5565201  (LI HONGZHI [CN]) [DX] 1-8 * claim 1 * * abstract * * column 1, line 1 - column 2, line 17 * * column 2, line 29 - line 61 *;
 [DA]FR2758086  (JEAN DANIEL [FR]) [DA] 1-8 * abstract * * page 3, line 29 - page 4, line 19 *;
 [XY]  - BAUDOIN T ET AL, "Capsaicin significantly reduces sinonasal polyps.", ACTA OTO-LARYNGOLOGICA. NORWAY MAR 2000, (200003), vol. 120, no. 2, ISSN 0001-6489, pages 307 - 311, XP008022518 [X] 1,2,7,8 * abstract * * page 307, column L, line 26 - column R, line 8 * * page 309, column L, line 3 - line 4 * * figure 2 * * page 310, column L, paragraph 2 * [Y] 3-6

DOI:   http://dx.doi.org/10.1080/000164800750001143
 [Y]  - SUEKAWA M ET AL, "[Pharmacological studies on ginger. V. Pharmacological comparison between (6)-shogaol and capsaicin]", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (198611), Database accession no. NLM3817651, XP002256080 [Y] 3-6 * abstract *
    [ ] - NIPPON YAKURIGAKU ZASSHI. JAPANESE JOURNAL OF PHARMACOLOGY. JAPAN NOV 1986, (198611), vol. 88, no. 5, ISSN 0015-5691, pages 339 - 347
 [A]  - ELSHERIF I ET AL, "The effect of nasal surgery on snoring.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (199803), Database accession no. NLM9578923, XP002256963 [A] 1-7 * abstract *
    [ ] - AMERICAN JOURNAL OF RHINOLOGY. UNITED STATES 1998 MAR-APR, (199803), vol. 12, no. 2, ISSN 1050-6586, pages 77 - 79
 [A]  - SZALLASI A ET AL, "VANILLOID (CAPSAICIN) RECEPTORS AND MECHANISMS", PHARMACOLOGICAL REVIEWS, WILLIAMS AND WILKINS INC., BALTIMORE, MD,, US, (1999), vol. 51, no. 2, ISSN 0031-6997, pages 159 - 211, XP001105620 [A] 1-8 * page 195, column L, paragraph 3 * * table 9 *
 [A]  - KANAMARU, ARATA ET AL, "Respiratory and cardiovascular reflexes elicited by nasal instillation of capsaicin to anesthetized, spontaneously breathing dogs", JOURNAL OF VETERINARY MEDICAL SCIENCE, (2001), vol. 63, no. 4, pages 439 - 443, XP008010414 [A] 1,2,7,8 * abstract * * page 442, column L, paragraph 2 - column R, paragraph 2 *

DOI:   http://dx.doi.org/10.1292/jvms.63.439
 [A]  - STJAERNE P ET AL, "LOCAL CAPSAICIN TREATMENT OF THE NASAL MUCOSA REDUCES SYMPTOMS IN PATIENTS WITH NONALLERGIC NASAL HYPERREACTIVITY", AMERICAN JOURNAL OF RHINOLOGY, OCEANSIDE PUBLICATIONS, PROVIDENCE, RI, US, (19910701), vol. 5, no. 4, ISSN 1050-6586, pages 145 - 151, XP000603517 [A] 1,2,7,8 * page 145, column R, paragraph 1 * * page 147, column L, paragraph 4 - page 148, column R, paragraph 3 *
 [A]  - WOLF G ET AL, "ÄNDERUNGEN DES NASALEN VOLUMSSTROMES NACH LOKALER APPLIKATION DES NEUROPEPTIDES SUBSTANZ-P UND VON CAPSAICIN", LARYNGOLOGIE RHINOLOGIE OTOLOGIE UND IHRE GRENZGEBIETE VEREINIGT MIT MONATSSCHRIFT FÜR OHRENHEILKUNDE, THIEME, STUTTGART, DE, (1987), vol. 66, no. 8, ISSN 0340-1588, pages 412 - 415, XP000603410 [A] 1,2,7,8 * page 413, column L, paragraph 11 - column R, paragraph 2 *
 [A]  - MARABINI S ET AL, "BENEFICIAL EFFECTS OF INTRANASAL APPLICATIONS OF CAPSAICIN IN PATIENTS WITH VASOMOTOR RHINITIS", EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, SPRINGER INTERNATIONAL, BERLIN, DE, (1991), vol. 248, no. 4, ISSN 0937-4477, pages 191 - 194, XP000603518 [A] 1,2,7,8 * page 191, column R, paragraph 2 - page 192, column L, paragraph 1 * * page 193, column L, paragraph 3 - column R, paragraph 2 *
 [A]  - CORDELL G A ET AL, "CAPSAICIN: IDENTIFICATION, NOMENCLATURE, AND PHARMACOTHERAPY", ANNALS OF PHARMACOTHERAPY, XX, XX, (19930301), vol. 27, no. 3, ISSN 1060-0280, pages 330 - 336, XP000604000 [A] 1,2,7,8 * the whole document *
 [A]  - VIRUS R M ET AL, "PHARMACOLOGIC ACTIONS OF CAPSAICIN: APPARENT INVOLVEMENT OF SUBSTANCE P AND SEROTONIN", LIFE SCIENCES, PERGAMON PRESS, OXFORD, GB, (19791008), vol. 25, no. 15, ISSN 0024-3205, pages 1273 - 1283, XP000604075 [A] 1,2,7,8 * page 1274, paragraph 2 - page 1275, paragraph 6 * * page 1279, paragraph 5 - page 1280, paragraph 3 *

DOI:   http://dx.doi.org/10.1016/0024-3205(79)90392-8
 [A]  - RAINS C ET AL, "TOPICAL CAPSAICIN A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL IN POST-HERPETIC NEURALGIA, DIABETIC NEUROPATHY AND OSTEOARTHRITIS", DRUGS AND AGING, ADIS INTERNATIONAL LTD, NZ, (1995), vol. 7, no. 4, ISSN 1170-229X, pages 317 - 328, XP000604002 [A] 1,2,7,8 * abstract * * page 319, column R, paragraph 2 - page 320, column L, paragraph 1 * * page 320, column R, paragraph 2 - page 324, column R, paragraph 3 * * page 326, column L, paragraph 4 - page 327, column L, paragraph 3 *
 [A]  - FRIBERG D ET AL, "Abnormal afferent nerve endings in the soft palatal mucosa of sleep apnoics and habitual snorers.", REGULATORY PEPTIDES. NETHERLANDS 23 JUL 1997, (19970723), vol. 71, no. 1, ISSN 0167-0115, pages 29 - 36, XP002256079 [A] 1-8 * abstract * * page 32, column R, paragraph 5 * * page 35, column L, paragraph L - page 35, column R, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/S0167-0115(97)01016-1
 [A]  - HEDNER J ET AL, "CAPSAICIN AND REGULATION OF RESPIRATION: INTERACTION WITH CENTRAL SUBSTANCE P MECHANISMS", JOURNAL OF NEURAL TRANSMISSION, SPRINGER VERLAG, VIENNA, AT, (1985), vol. 61, no. 3/4, ISSN 0300-9564, pages 239 - 252, XP008010416 [A] 1,2,7,8 * abstract * * page 240, paragraph 1 * * page 241, paragraph 2 * * page 243, paragraph 3 - page 248, paragraph 1 * * page 250, paragraphs 2,4 * * tables 1-3 *

DOI:   http://dx.doi.org/10.1007/BF01251915
 [A]  - KOPCZYNSKA B ET AL, "APNOEIC RESPONSES TO PULMONARY AND SYSTEMIC CHALLENGE OF CAPSAICIN IN CATS", JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, POLISH PHYSIOLOGICAL SOCIETY, KRAKHAW, PL, (199803), vol. 49, no. 1, ISSN 0867-5910, pages 25 - 35, XP008010415 [A] 1,2,7,8 * abstract * * page 25, paragraph 1 * * page 31, paragraph 4 * * page 33, paragraph 3 - paragraph 4 *
 [A]  - MITCHELL H W ET AL, "REFLEX CHANGES IN RESPIRATION AND HEART RATE EVOKED BY INTRAVENOUS AND LEFT VENTRICULAR INJECTION OF 5-HT AND CAPSAICIN IN ANAESTHETIZED RATS: A COMPARISON OF MECHANISMS", LUNG, (1984), vol. 162, no. 3, pages 153 - 163, XP008010417 [A] 1,2,7,8 * abstract * * page 159, paragraph 1 - paragraph 2 * * page 162, paragraph 1 *
 [A]  - HAXHIU M A ET AL, "Influence of respiratory drive on airway responses to excitation of lung C-fibers.", JOURNAL OF APPLIED PHYSIOLOGY (BETHESDA, MD.: 1985) UNITED STATES JUL 1989, (198907), vol. 67, no. 1, ISSN 8750-7587, pages 203 - 209, XP008022529 [A] 1,2,7,8 * abstract * * page 206, column R, paragraph 4 * * page 208, column L, paragraph 2 * * page 208, column R, paragraph 5 *
 [A]  - MITCHELL H W, "ANALYSIS BY MICROCOMPUTER OF THE EFFECT OF CAPSAICIN ON PULMONARY MECHANICS IN THE RAT AND GUINEA-PIG", ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE, DOIN, PARIS, BE, (198506), vol. 275, no. 2, ISSN 0301-4533, pages 279 - 286, XP008021979 [A] 1,2,7,8 * abstract * * page 280, paragraph 2 * * page 285, paragraph 2 - page 286, paragraph 1 *
 [A]  - CLIFFORD P S ET AL, "PULMONARY DEPRESSOR REFLEX ELICITED BY CAPSAICIN IN CONSCIOUS INTACT AND LUNG-DENERVATED DOGS", AMERICAN JOURNAL OF PHYSIOLOGY, AMERICAN PHYSIOLOGICAL SOCIETY, BETHESDA, MD, US, (1987), vol. 252, no. 2, PART 2, ISSN 0002-9513, pages 394 - 397, XP008021980 [A] 1,2,7,8 * abstract * * page R396, column R, paragraph 3 - page R397, column L, paragraph 4 *
 [A]  - PALECEK F ET AL, "Reflex responses to capsaicin: intravenous, aerosol, and intratracheal administration.", JOURNAL OF APPLIED PHYSIOLOGY (BETHESDA, MD.: 1985) UNITED STATES OCT 1989, (198910), vol. 67, no. 4, ISSN 8750-7587, pages 1428 - 1437, XP008022531 [A] 1,2,7,8 * abstract * * page 1436, column L, paragraph 4 - column R, paragraph 2 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.